Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Management of acute respiratory distress syndrome and refractory hypoxemia a multicenter observational study

Annals of the American Thoracic Society, Volume 14, No. 12, Year 2017

Rationale: Clinicians' current practice patterns in the management of acute respiratory distress syndrome (ARDS) and refractory hypoxemia are not well described. Objectives: To describe mechanical ventilation strategies and treatment adjuncts for adults with ARDS, including refractory hypoxemia. Methods: This was a prospective cohort study (March 2014-February 2015) of mechanically ventilated adults with moderate-To-severe ARDS requiring an FIO2 of 0.50 or greater in 24 intensive care units. Results:We enrolled 664 patients: 222 (33%) with moderate and 442 (67%) with severe ARDS. On Study Day 1,mean VT was 7.5 (SD = 2.1) ml/kg predicted body weight (n = 625); 80% (n = 501) received VT greater than 6 ml/kg. Mean positive end-expiratory pressure (PEEP) was 10.5 (3.7) cm H2O (n = 653); 568 patients (87%) received PEEP less than 15 cmH2O. Treatment adjunctswere common (n = 440, 66%): neuromuscular blockers (n = 276, 42%), pulmonary vasodilators (n = 118, 18%), prone positioning (n = 67, 10%), extracorporeal life support (n = 29, 4%), and high-frequency oscillatory ventilation (n = 29, 4%). Refractory hypoxemia, defined as PaO2 less than 60 mm Hg on FIO2 of 1.0, occurred in 138 (21%) patients.At onset of refractory hypoxemia,meanVT was 7.1 (SD= 2.0) ml/kg (n = 124); 95 patients (77%) received VT greater than 6 ml/kg. Mean PEEP was 12.1 (SD = 4.4) cm H2O (n = 133); 99 patients (74%) received PEEP less than 15 cm H2O. Among patients with refractory hypoxemia, 91% received treatment adjuncts (126/138), with increased use of neuromuscular blockers (n = 87, 63%), pulmonary vasodilators (n = 57, 41%), and prone positioning (n = 32, 23%). Conclusions: Patients with moderate-To-severe ARDS receive treatment adjuncts frequently, especially with refractory hypoxemia. Paradoxically, therapies with less evidence supporting their use (e.g., pulmonary vasodilators) were over-used, whereas those with more evidence (e.g., prone positioning, neuromuscular blockade) were under-used. Patients received higher VTs and lower PEEP than would be suggested by the evidence.

Statistics
Citations: 54
Authors: 30
Affiliations: 22
Study Design
Cohort Study
Study Approach
Quantitative